• SENSEX
    NIFTY 50
Market

Thursday's biggest brokerage calls: Dr Lal Pathlabs, L&T and more

Updated : 2020-03-26 08:27:27

Indian indices are likely to open lower on Thursday as the US stimulus package failed to lift the sentiments of the Asian markets despite the Wall Street ending higher last night on the United States' 2 trillion rescue plan to overcome the coronavirus onslaught. Among brokerages, Morgan Stanley was 'overweight' on L&T, while CLSA reiterated 'buy' call on Dr Lal Pathlabs but cut its target price. Here are the top brokerage calls for today:

 CLSA on Dr Lal Pathlabs:  The brokerage reiterated 'buy' call on the stock but cut its target price to Rs 1,860 per share from Rs 2,100 earlier. It added that the company is well placed to capitalise on volume-led growth story.
CLSA on Dr Lal Pathlabs: The brokerage reiterated 'buy' call on the stock but cut its target price to Rs 1,860 per share from Rs 2,100 earlier. It added that the company is well placed to capitalise on volume-led growth story.
 Morgan Stanley on L&T:  The brokerage was 'overweight' on the stock with the target price at Rs 941 per share. It added that sharp correction in the stock provides a good opportunity for long-term investors.
Morgan Stanley on L&T: The brokerage was 'overweight' on the stock with the target price at Rs 941 per share. It added that sharp correction in the stock provides a good opportunity for long-term investors.
 Credit Suisse on Bharti Infratel : The brokerage maintained 'underperform' call on the stock with the target price cut to Rs 120 per share from Rs 200 earlier. In a two-player scenario, the investment case for the company could get severely dented, it added.
Credit Suisse on Bharti Infratel: The brokerage maintained 'underperform' call on the stock with the target price cut to Rs 120 per share from Rs 200 earlier. In a two-player scenario, the investment case for the company could get severely dented, it added.
 Credit Suisse on Hind Zinc:  The brokerage upgraded the stock to 'outperform' but cut its target price to Rs 195 per share from Rs 230 earlier.
Credit Suisse on Hind Zinc: The brokerage upgraded the stock to 'outperform' but cut its target price to Rs 195 per share from Rs 230 earlier.
 Nomura on India:  The 21-day lockdown will result in a direct output loss of 4.5 percent, said the brokerage. It further expects the central government to soon announce a stimulus package of 0.7-1.1 percent of the country's gross domestic product.
Nomura on India: The 21-day lockdown will result in a direct output loss of 4.5 percent, said the brokerage. It further expects the central government to soon announce a stimulus package of 0.7-1.1 percent of the country's gross domestic product.
 CLSA India Strategy:  The crash in oil prices may not provide a fiscal boost, CLSA said. It added that crude crash will reduce revenue by $4 billion from royalties, cesses and dividends.
CLSA India Strategy: The crash in oil prices may not provide a fiscal boost, CLSA said. It added that crude crash will reduce revenue by $4 billion from royalties, cesses and dividends.
Live TV

recommended for you

Ask Our Experts CNBC TV18

Advertisement